98%
921
2 minutes
20
Advancements in deep learning have led to significant progress in no-reference (NR) image quality assessment (NR-IQA) for evaluating the perceived quality of digital images without relying on a reference. However, existing NR-IQA models remain suboptimal in handling complex and diverse natural images. Visual saliency constitutes a critical element for enhancing the reliability of NR-IQA, but the optimal use of saliency in deep learning-based NR-IQA has not heretofore been significantly explored. In this article, we present a novel method for integrating saliency in NR-IQA, which is motivated by the saliency-based visual search mechanism that different parts of the visual input are visited by the focus of attention (FOA) in the order of decreasing saliency. By dividing saliency into the high and low levels of FOA, we build a bioinspired deep neural network-BioSIQNet-based on a multitask learning (MTL) framework. The network architecture consists of two saliency-specific tasks and one primary image quality assessment (IQA) task. The low and high saliency (HS) are separately encoded and integrated into the early and deeper layers of the IQA network, respectively, analogous to the hierarchical processing in the visual cortex of the brain that allocates low attentional resources to process the simple patterns and high resources to learn intricate representations. We demonstrate that leveraging the synergy between visual attention and image quality perception and joint learning of these interconnected visual tasks can enhance the overall learning capabilities of the primary IQA model. Experiments validate the effectiveness of our proposed BioSIQNet for NR-IQA.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/TNNLS.2025.3598716 | DOI Listing |
JAMA
September 2025
Division of Surgery and Interventional Science, UCL, London, United Kingdom.
Importance: Multiparametric magnetic resonance imaging (MRI), with or without prostate biopsy, has become the standard of care for diagnosing clinically significant prostate cancer. Resource capacity limits widespread adoption. Biparametric MRI, which omits the gadolinium contrast sequence, is a shorter and cheaper alternative offering time-saving capacity gains for health systems globally.
View Article and Find Full Text PDFJAMA
September 2025
Section of Urologic Oncology, Department of Urology, Michigan Medicine, Ann Arbor.
JAMA Cardiol
September 2025
Seymour, Paul and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, New York.
Importance: Transthyretin cardiac amyloidosis (ATTR-CA) is an underdiagnosed but treatable cause of heart failure (HF) in older individuals that occurs in the context of normal wild-type (ATTRwt-CA) or an abnormal inherited (ATTRv-CA) TTR gene variant. While the most common inherited TTR variant, V142I, occurs in 3% to 4% of self-identified Black Americans and is associated with excess morbidity and mortality, the prevalence of ATTR-CA in this at-risk population is unknown.
Objective: To define the prevalence of ATTR-CA and proportions attributable to ATTRwt-CA or ATTRv-CA among older Black and Caribbean Hispanic individuals with HF.
Phys Eng Sci Med
September 2025
Department of Physics, Faculty of Mathematics and Natural Sciences, Universitas Indonesia, Depok, 16424, Indonesia.
This study introduces a novel optimization framework for cranial three-dimensional rotational angiography (3DRA), combining the development of a brain equivalent in-house phantom with Figure of Merit (FOM) a quantitative evaluation method. The technical contribution involves the development of an in-house phantom constructed using iodine-infused epoxy and lycal resins, validated against clinical Hounsfield Units (HU). A customized head phantom was developed to simulate brain tissue and cranial vasculature for 3DRA optimization.
View Article and Find Full Text PDFActa Neurochir (Wien)
September 2025
Department of Neurosurgery, Medical University of Gdańsk, Gdańsk, Poland.
Purpose: Moyamoya disease (MMD) is a chronic cerebrovascular disorder characterized by progressive arterial stenosis and fragile collateral formation, elevating stroke risk. Revascularization is the standard treatment, yet up to 27% of patients experience ischemic events within a year due to bypass insufficiency. While digital subtraction angiography (DSA) remains the gold standard for assessing bypass function, it is invasive and time-consuming.
View Article and Find Full Text PDF